Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Taubman Centers, Inc. (TCO) Going to Burn These Hedge Funds?

Page 1 of 2

What’s a smart Taubman Centers, Inc. (NYSE:TCO) investor to do?

At the moment, there are tons of methods shareholders can use to watch stocks. Some of the most under-the-radar are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the top fund managers can beat the S&P 500 by a healthy amount (see just how much).

Equally as crucial, optimistic insider trading activity is another way to look at the investments you’re interested in. Obviously, there are many incentives for a corporate insider to sell shares of his or her company, but just one, very simple reason why they would initiate a purchase. Several empirical studies have demonstrated the valuable potential of this method if investors know what to do (learn more here).

Furthermore, it’s important to discuss the recent info about Taubman Centers, Inc. (NYSE:TCO).

How are hedge funds trading Taubman Centers, Inc. (NYSE:TCO)?

Heading into Q3, a total of 19 of the hedge funds we track held long positions in this stock, a change of 27% from the previous quarter. With the smart money’s capital changing hands, there exists a select group of noteworthy hedge fund managers who were increasing their stakes considerably.

Taubman Centers, Inc. (NYSE:TCO)When using filings from the hedgies we track, D. E. Shaw’s D E Shaw had the biggest position in Taubman Centers, Inc. (NYSE:TCO), worth close to $71.8 million, comprising 0.1% of its total 13F portfolio. The second largest stake is held by Capital Growth Management, managed by Ken Heebner, which held a $44.3 million position; 1.2% of its 13F portfolio is allocated to the stock. Some other hedgies that hold long positions include John Overdeck and David Siegel’s Two Sigma Advisors, Ken Griffin’s Citadel Investment Group and Jim Simons’s Renaissance Technologies.

As one would understandably expect, certain money managers were breaking ground themselves. D E Shaw, managed by D. E. Shaw, initiated the most outsized position in Taubman Centers, Inc. (NYSE:TCO). D E Shaw had 71.8 million invested in the company at the end of the quarter. Ken Heebner’s Capital Growth Management also made a $44.3 million investment in the stock during the quarter. The other funds with brand new TCO positions are John Overdeck and David Siegel’s Two Sigma Advisors, Ken Griffin’s Citadel Investment Group, and Jim Simons’s Renaissance Technologies.

What have insiders been doing with Taubman Centers, Inc. (NYSE:TCO)?

Insider buying made by high-level executives is particularly usable when the company in focus has seen transactions within the past 180 days. Over the latest 180-day time period, Taubman Centers, Inc. (NYSE:TCO) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll also review the relationship between both of these indicators in other stocks similar to Taubman Centers, Inc. (NYSE:TCO). These stocks are Hospitality Properties Trust (NYSE:HPT), CBL & Associates Properties, Inc. (NYSE:CBL), Weingarten Realty Investors (NYSE:WRI), DDR Corp (NYSE:DDR), and Regency Centers Corp (NYSE:REG). This group of stocks are in the reit – retail industry and their market caps are similar to TCO’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!